haloperidol- haloperidol lactate injection
cardinal health - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol injection, usp is indicated for use in the treatment of schizophrenia. haloperidol injection, usp is indicated for the control of tics and vocal utterances of tourette's disorder. haloperidol injection is contraindicated in severe toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this drug or have parkinson's disease.
haloperidol- haloperidol lactate injection, solution
hf acquisition co llc, dba healthfirst - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol injection is indicated for use in the treatment of schizophrenia. haloperidol is indicated for the control of tics and vocal utterances of tourette's disorder. haloperidol injection is contraindicated in severe toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this drug or have parkinson’s disease.
haloperidol 5mg/5ml oral solution sugar free
pinewood healthcare - haloperidol - oral solution - 1mg/1ml
haloperidol 10mg/5ml oral solution sugar free
pinewood healthcare - haloperidol - oral solution - 2mg/1ml
haloperidol injection solution
omega laboratories limited - haloperidol - solution - 5mg - haloperidol 5mg - butyrophenones
haloperidol lactate- haloperidol injection, solution
henry schein, inc. - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol injection, usp is indicated for use in the treatment of schizophrenia. haloperidol injection is indicated for the control of tics and vocal utterances of tourette's disorder. haloperidol injection is contraindicated in patients with: • severe toxic central nervous system depression or comatose states from any cause. • hypersensitivity to this drug – hypersensitivity reactions have included anaphylactic reaction and angioedema (see warnings, hypersensitivity reactions and adverse reactions). • parkinson’s disease (see warnings, neurological adverse reactions in patients with parkinson’s disease or dementia with lewy bodies). • dementia with lewy bodies (see warnings, neurological adverse reactions in patients with parkinson’s disease or dementia with lewy bodies).
haloperidol inj 5mg/ml usp liquid
sandoz canada incorporated - haloperidol - liquid - 5mg - haloperidol 5mg - butyrophenones
haloperidol lactate injection, solution
remedyrepack inc. - haloperidol lactate (unii: 6387s86pk3) (haloperidol - unii:j6292f8l3d) - haloperidol injection is indicated for the treatment of patients with schizophrenia. haloperidol is contraindicated in patients with: - severe toxic central nervous system depression or comatose states from any cause. - hypersensitivity to this drug – hypersensitivity reactions have included anaphylactic reaction and angioedema (see warnings, hypersensitivity reactions and adverse reactions ). - parkinson’s disease (see warnings, neurological adverse reactions in patients with parkinson’s disease or dementia with lewy bodies ). - dementia with lewy bodies (see warnings, neurological adverse reactions in patients with parkinson’s disease or dementia with lewy bodies ).
haloperidol la liquid
sandoz canada incorporated - haloperidol (haloperidol decanoate) - liquid - 50mg - haloperidol (haloperidol decanoate) 50mg - butyrophenones
haloperidol la liquid
sandoz canada incorporated - haloperidol (haloperidol decanoate) - liquid - 100mg - haloperidol (haloperidol decanoate) 100mg - butyrophenones